Lysosomal Alpha-Glucosidase Market Analysis: Emerging Applications and Forecast
The Lysosomal Alpha-Glucosidase Market is becoming an important segment of the rare-disease treatment industry as the diagnosis and management of Pompe disease continue to improve. The market was valued at approximately USD 2 billion in 2025 and is projected to reach USD 5 billion by 2035, reflecting a 6.6% CAGR from 2026 to 2035. Growing healthcare expenditure, research activity, and demand...
0 Комментарии 0 Поделились 9 Просмотры 0 предпросмотр